Matthew Gdovin, an associate professor in the UTSA Department of Biology, has developed a newly patented method to kill cancer cells. His discovery, described in research published in The Journal of Clinical Oncology, may tremendously help people with inoperable or hard-to-reach tumors, as well as young children stricken with cancer.
Gdovin’s top-tier research involves injecting a chemical compound, nitrobenzaldehyde, into the tumor and allowing it to diffuse into the tissue. He then aims a beam of light at the tissue, causing the cells to become very acidic inside and, essentially, commit suicide. Within two hours, Gdovin estimates up to 95 percent of the targeted cancer cells are dead.
“Even though there are many different types of cancers, the one thing they have in common is their susceptibility to this induced cell suicide,” he said.
Gdovin tested his method against triple negative breast cancer, one of the most aggressive types of cancer and one of the hardest to treat. The prognosis for triple negative breast cancer is usually very poor. After one treatment in the laboratory, he was able to stop the tumor from growing and double chances of survival in mice.
“All forms of cancer attempt to make cells acidic on the outside as a way to attract the attention of a blood vessel, which attempts to get rid of the acid,” he said. “Instead, the cancer latches onto the blood vessel and uses it to make the tumor larger and larger.”
Chemotherapy treatments target all cells in the body, and certain chemotherapeutics try to keep cancer cells acidic as a way to kill the cancer. This is what causes many cancer patients to lose their hair and become sickly. Gdovin’s method, however, is more precise and can target just the tumor.
In the past two years, he’s developed his photodynamic cancer therapy to the point where it’s non-invasive. It now requires just an injection of the nitrobenzaldehyde fluid followed by a flash of an ultraviolet light to cause the cancer-killing reaction. Gdovin has now begun to test the method on drug-resistant cancer cells to make his therapy as strong as possible. He’s also started to develop a nanoparticle that can be injected into the body to target metastasized cancer cells. The nanoparticle is activated with a wavelength of light that it can pass harmlessly through skin, flesh and bone and still activate the the cancer-killing nanoparticle.
Gdovin hopes that his non-invasive method will help cancer patients with tumors in areas that have proven problematic for surgeons, such as the brain stem, aorta or spine. It could also help people who have received the maximum amount of radiation treatment and can no longer cope with the scarring and pain that goes along with it, or children who are at risk of developing mutations from radiation as they grow older.
“There are so many types of cancer for which the prognosis is very poor,” he said. “We’re thinking outside the box and finding a way to do what for many people is simply impossible.”
The Latest on: Photodynamic cancer therapy
via Google News
The Latest on: Photodynamic cancer therapy
- Management of Nonmelanoma Skin Cancer in 2007on May 24, 2020 at 5:00 pm
As the incidence of nonmelanoma skin cancer (NMSC) increases ... retinoids, and photodynamic therapy, which can be used particularly in patients with superficial tumors. Treatments should be ...
- The Enlightenment of Bladder Cancer Treatmenton May 22, 2020 at 5:00 pm
Galvanic cautery, the treatment ... cancer.  Table 1. Relevant publications on prospective randomized studies concerning residual tumor rate and recurrence-free survival rate for ...
- CityU researchers cast new light on anti-cancer treatmenton May 22, 2020 at 2:30 am
The compound, called phorbiplatin, offers hope for minimising the damage that “normal” cells undergo during treatment for a broad range of cancers, in particular for breast and ovarian cancers.
- Lung Cancer Market Overview, Top Key Players, Growth Analysis and Segments by Forecast to 2026on May 21, 2020 at 7:35 am
According to a recent research study "Lung Cancer Market, By Type (SCLC, NSCLC), By Treatment (Surgery, Radiotherapy, Chemotherapy, Laser Therapy, Photodynamic Therapy) By Application (Hospitals ...
- What is staging for non-small-cell lung cancer?on May 20, 2020 at 5:00 pm
"Immunotherapy for Non-Small Cell Lung Cancer." The Society of Thoracic Surgeons: “Lung/Thoracic Surgery.” Penn Medicine: “Photodynamic Therapy (PDT).” Journal of Thoracic Disease ...
- Photodynamic Therapy Market to See Huge Growth by 2030 | Theralase Technologies Inc., LUMIBIRD, Quest PharmaTech Inc., Modulighton May 13, 2020 at 1:39 am
Photodynamic therapy (PDT) is a medical treatment for cancer that uses photosynthesizing substances with light to kill the cancer causing cells. This therapy has proved its efficiency to destroy ...
- PMR : Non Melanoma Skin Cancer Market to Grow at Stellar CAGR 6.4% During the Forecast Period 2025on May 11, 2020 at 11:46 pm
Non-melanoma skin cancer is more prevalent in senior citizens ... Treatment Type – Radiation Therapy Larger than Chemotherapy and Photodynamic Therapy Radiation therapy is larger than ...
- Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumorson May 7, 2020 at 5:00 pm
Photodynamic therapy (PDT ... to a greater extent than VP in breast cancer cells both in vitro and in vivo, resulting in increased treatment efficacy of HS201-PDT in various human breast cancer ...
- Photochemical Targeting Strategies to Improve Therapeutic Efficacy in Ovarian Canceron April 27, 2020 at 9:24 am
Ovarian cancer is the deadliest gynecologic malignancy and is ... which correlates with poor survival and chemoresistance. Photodynamic therapy (PDT) uses a light-activatable photosensitizer (PS) and ...
- Ray of light for prostate cancer treatmenton December 25, 2019 at 5:34 pm
An Israeli-developed photodynamic therapy that killed early stage prostate cancer tumours in 90 minutes in trials, and causes minimal side effects, is being further tested. Jim Drury reports.
via Bing News